Elan dropped 10% Tuesday over liver-damage concerns, butthe price started inching back up after the FDA clarified its warning. Now's the time to buy the stock while it's still a bargain.
Read More...
[Source: MSN Money Latest Articles]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment